Spyre Therapeutics, Inc.

Report date
9/30/2021
Quarter
2021 Q3
Filed
5/17/2024
Shares
15,353
Value ($000)
122
Weight
0.0%
2019 Q3 - 2021 Q3 (6 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).